Nicole LaBrosse
Director of Finance/CFO presso HALOZYME THERAPEUTICS, INC.
Patrimonio netto: 629 726 $ in data 31/03/2024
Profilo
Nicole LaBrosse is currently the Director at Antares Pharma, Inc. and the Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. She previously worked as an Auditor at PricewaterhouseCoopers LLP from 2004 to 2015.
Ms. LaBrosse has an undergraduate and graduate degree from Bentley University and a graduate degree from McCallum Graduate School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/02/2024 | 15 480 ( 0.01% ) | 629 726 $ | 31/03/2024 |
Posizioni attive di Nicole LaBrosse
| Società | Posizione | Inizio |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 02/02/2022 |
| ANTARES PHARMA, INC. | Director/Board Member | 24/05/2022 |
Precedenti posizioni note di Nicole LaBrosse
| Società | Posizione | Fine |
|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01/01/2015 |
Formazione di Nicole LaBrosse
| McCallum Graduate School of Business | Graduate Degree |
| Bentley University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Borsa valori
- Insiders
- Nicole LaBrosse
